Management Team

Spencer Williamson

Spencer is President, Chief Executive Officer and a member of our board of directors. Prior to joining kaléo, he spent 15 years with Guidant Corporation (now Boston Scientific Corporation) in a variety of sales, marketing, business development and general management positions. He began his career in the Medical Devices and Diagnostics (MDD) Division of Eli Lilly & Company, which was spun off from Lilly to become Guidant in 1994. Spencer serves on the board of directors of several private life science companies and is a member of the VABIO (Virginia Biotechnology Association) board of directors.

Spencer holds a BS in Civil Engineering from the Virginia Military Institute, and an MBA from the University of North Carolina, Chapel Hill.

Spencer is a 2013 Ernst & Young Entrepreneur Of The Year® Award Winner.

Eric Edwards

Eric is Vice President of Product Strategy for kaléo. He is responsible for both co-founding our company and co-inventing our technology platforms.

Eric received a BS in Biology with honors from Virginia Commonwealth University (VCU), received his Ph.D in the pharmaceutical sciences from VCU’s School of Pharmacy and his MD from the VCU’s School of Medicine (formerly the Medical College of Virginia).

Evan Edwards

As Vice President of Product Development and Industrialization, Evan manages all areas of our invention and design process, including kaléo‘s intellectual property portfolio. In addition, he is a co-founder of our company and the co-inventor of our technology platforms.

Evan has been recognized among his peers for his expertise and work in human factors engineering (HFE) and is actively involved with the Human Factors & Ergonomics Society (HFES). He serves on the Medical Devices for Injection and Human Factors Committees for the Association of the Advancement of Medical Instrumentation (AAMI).

Evan is a graduate of the University of Virginia where he earned a BS in Mechanical Engineering and an MS in Systems Engineering with a concentration on HFE.

Kris Ford

Kris, our EVZIO General Manager and Vice President of Business Development, is responsible for all aspects of our EVZIO business. Kris has 20 years of pharmaceutical/biotechnical experience including in-and-out licensing, co-promotion, M&A, joint ventures, sales and marketing, and IPOs. Prior to joining kaléo, Kris spent six years as the Vice President of Business Development for UCB Pharma North America. He began his career with Bristol-Myers Squibb, and has held leadership roles at AAI Pharma, Oasis Biosciences and Inceutica.

Kris holds BS and MS degrees from NC State University in Raleigh and an MBA from the University of North Carolina in Wilmington.

Ron Gunn

Ron is kaléo‘s Chief Operating Officer. He is responsible for directing all aspects of our manufacturing, quality assurance, medical affairs, development and regulatory affairs. Ron has over 25 years of pharmaceutical/biotechnology development and operations experience. Prior to joining kaléo, Ron served as Executive Vice President and Chief Operating Officer for Insmed Incorporated where his responsibilities included R&D, Regulatory Affairs, Finance, Manufacturing and Quality Assurance. Ron has directed the strategic development, compilation, submission and management of several INDs and NDAs. Prior to joining Insmed, he held several clinical, business development and operational positions with domestic and foreign companies within the pharmaceutical industry.

Ron received a BS from Radford University and received his MS in Statistics and MBA from Virginia Commonwealth University.

Ned Ruffin

Ned is kaléo‘s Vice President and General Counsel. He is responsible for all legal matters affecting kaléo. Ned has over 20 years experience representing emerging growth companies in the life sciences and technology sectors spending the majority of his career working in Silicon Valley. He has helped build numerous companies from formation to successful public offering and acquisition, including PayPal (acquired by eBay), Infinera (INFN) and Eos Biotechnology (acquired by Protein Design Labs). Prior to joining kaléo, Ned was a partner in the Emerging Companies Group at Orrick, Herrington & Sutcliffe LLP.

Ned received his JD and MBA from the College of William & Mary and received his BA from the University of Texas.

Chris Schools

Chris, our Chief Financial Officer, has over 20 years of experience in a broad range of management, treasury, financial and accounting roles. Prior to joining kaléo, Chris served as Vice President of Planning & Analysis for LandAmerica Financial Group, Inc. He also spent 11 years with Cadmus Communications Corporation, including 5 years as Vice President and Treasurer. Chris began his career in public accounting at Coopers & Lybrand, LLP.

Chris holds a BS in Commerce, with a concentration in Accounting, from the University of Virginia. He is a CPA licensed in the Commonwealth of Virginia.

In Memoriam

Mark Licata

Mark served as kaléo‘s Vice President of Industrialization and Quality. He was responsible for the engineering, late phase development and quality assurance activities for our company. Mark had been in the medical device industry for more than 25 years working at Bayer USA and Medtronic, as well as a number of start-up companies. He had been granted 25 patents in the medical device field and was a member of both the Society for Biomaterials and the American Association of Pharmaceutical Sciences.

Mark earned a Masters degree in Colloids, Polymers, Surfaces, and Biomedical Engineering from Carnegie-Mellon University.